APA (7th ed.) Citation

L, Z., X, H., Y, C., W, Y., K, S., & X, Z. (2026). Infection risk in inflammatory bowel disease patients treated with vedolizumab: A systematic review and meta-analysis. Frontiers in medicine, 13, 1806488. https://doi.org/10.3389/fmed.2026.1806488

Chicago Style (17th ed.) Citation

L, Zhang, Hao X, Cui Y, Yan W, Shang K, and Zhang X. "Infection Risk in Inflammatory Bowel Disease Patients Treated with Vedolizumab: A Systematic Review and Meta-analysis." Frontiers in Medicine 13 (2026): 1806488. https://doi.org/10.3389/fmed.2026.1806488.

MLA (9th ed.) Citation

L, Zhang, et al. "Infection Risk in Inflammatory Bowel Disease Patients Treated with Vedolizumab: A Systematic Review and Meta-analysis." Frontiers in Medicine, vol. 13, 2026, p. 1806488, https://doi.org/10.3389/fmed.2026.1806488.